Back
Cidara Therapeutics Stock Price Chart
Sponsored
CDTX
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
62
CDTX
Cidara Therapeutics
Last Price:
14.66
Seasonality Move:
7.85%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cidara Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.37 | Buy |
20-day SMA: | 12.59 | Buy |
50-day SMA: | 11.68 | Buy |
200-day SMA: | 12.96 | Buy |
8-day EMA: | 13.38 | Buy |
20-day EMA: | 12.73 | Buy |
50-day EMA: | 12.15 | Buy |
200-day EMA: | 13.17 | Buy |
Cidara Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 71.09 | Buy |
Chaikin Money Flow: | 22295 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.97 - 13.37) | Buy |
Bollinger Bands (100): | (11.04 - 12.84) | Buy |
Cidara Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 13.94 while CDTX 8-day simple moving average is 13.37, which is a Buy signal.
- The stock price of CDTX is 13.94 while Cidara Therapeutics 20-day SMA is 12.59, which makes it a Buy.
- Cidara Therapeutics 50-day simple moving average is 11.68 while CDTX share price is 13.94, making it a Buy technically.
- CDTX stock price is 13.94 and Cidara Therapeutics 200-day simple moving average is 12.96, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a Buy
The current Cidara Therapeutics [CDTX] share price is $13.94. The Score for CDTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
98.11M
Price in USD:
13.94
Share Volume:
26.68K
Cidara Therapeutics 52-Week Range
52-Week High:
24.40
52-Week Low:
10.00
Buy
62
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?
The Cidara Therapeutics stock price is 13.94 USD today. -
Will CDTX stock go up or go down?
Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cidara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 13.94 while CDTX 8-day exponential moving average is 13.38, which is a Buy signal.
- The stock price of CDTX is 13.94 while Cidara Therapeutics 20-day EMA is 12.73, which makes it a Buy.
- Cidara Therapeutics 50-day exponential moving average is 12.15 while CDTX share price is 13.94, making it a Buy technically.
- CDTX stock price is 13.94 and Cidara Therapeutics 200-day simple moving average is 13.17, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
- CDTX Moving Average Covergence Divergence (MACD) indicator is 0.62, suggesting Cidara Therapeutics is a Buy
- Cidara Therapeutics Relative Strength Index (RSI) is 71.09, which suggest Cidara Therapeutics is overbought
- The Bollinger Bands (25) for Cidara Therapeutics is (10.97 - 13.37), which suggest Cidara Therapeutics is a Buy
- The Bollinger Bands (100) for Cidara Therapeutics is (11.04 - 12.84), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.